Qian, X., et al. (2025). Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα ...

Fatty acid oxidation disorders (FAODs) comprise more than 20 defects in mitochondrial β-oxidation and fatty acid transport and are inherited in an autosomal recessive pattern. 1,2 Newborn testing ...

The U.S. Food and Drug Administration (FDA) approved Dojolvi on June 30, 2020 as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed ...

A New Drug Application (NDA) has been submitted to the Food and Drug Administration (FDA) for triheptanoin (Ultragenyx) for the treatment of long-chain fatty acid oxidation disorders.

Laurence Moire, Enea Rezzonico, Simon Goepfert, Yves Poirier, Impact of Unusual Fatty Acid Synthesis on Futile Cycling through β-Oxidation and on Gene Expression in Transgenic Plants, Plant Physiology ...

The Food and Drug Administration (FDA) has approved Dojolvi™ (triheptanoin; Ultragenyx) as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly ...